Genetic material should be routinely collected in clinical vaccine trials - High consent rates can be achieved across all age groups

These high acceptance rates demonstrate that participants (and parents of young children) in vaccine studies are willing to consent and engage in genetic research, which provides support for routinely collecting genetic material in research involving healthy participants such as clinical vaccine trials.